doi: 10.1111/j.1469-0691.2004.00807.x.
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece
Affiliations
- PMID: 14706091
- DOI: 10.1111/j.1469-0691.2004.00807.x
Item in Clipboard
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece
Clin Microbiol Infect.
2004 Jan.
Free article
Abstract
Susceptibility data for 10 049 Escherichia coli isolates derived from community-acquired urinary tract infections in Greece during the period January 2000 to June 2002 indicated 8.1% resistance to nalidixic acid and 36% resistance to ciprofloxacin. In a sample of 170 E. coli isolates, mutations in gyrA (25 isolates) and parC (15 isolates) were consistent with the levels of resistance to quinolones. Previous exposure to quinolones and underlying chronic disease were independent risk factors for infection by quinolone-resistant E. coli strains.
Similar articles
-
Determinants of quinolone resistance in Escherichia coli causing community-acquired urinary tract infection in Bejaia, Algeria.Asian Pac J Trop Med. 2014 Jun;7(6):462-7. doi: 10.1016/S1995-7645(14)60075-4. Asian Pac J Trop Med. 2014. PMID: 25066395
-
Determination of gyrA and parC mutations and prevalence of plasmid-mediated quinolone resistance genes in Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infection in Iran.J Glob Antimicrob Resist. 2018 Jun;13:197-200. doi: 10.1016/j.jgar.2018.04.017. Epub 2018 May 7. J Glob Antimicrob Resist. 2018. PMID: 29747008
-
Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.Diagn Microbiol Infect Dis. 2000 Jan;36(1):61-4. doi: 10.1016/s0732-8893(99)00121-2. Diagn Microbiol Infect Dis. 2000. PMID: 10744370
-
Community-Acquired Urinary Tract Infection by Escherichia coli in the Era of Antibiotic Resistance.Biomed Res Int. 2018 Sep 26;2018:7656752. doi: 10.1155/2018/7656752. eCollection 2018. Biomed Res Int. 2018. PMID: 30356438 Free PMC article. Review.
-
Risk factors for quinolone-resistant Escherichia coli infection: a systematic review and meta-analysis.Antimicrob Resist Infect Control. 2020 Jan 9;9(1):11. doi: 10.1186/s13756-019-0675-3. eCollection 2020. Antimicrob Resist Infect Control. 2020. PMID: 31938541 Free PMC article.
Cited by
-
Trends of mortality due to septicemia in Greece: an 8-year analysis.PLoS One. 2013 Jul 2;8(7):e67621. doi: 10.1371/journal.pone.0067621. Print 2013. PLoS One. 2013. PMID: 23844042 Free PMC article.
-
Emergence of and risk factors for ciprofloxacin-gentamicin-resistant Escherichia coli urinary tract infections in a region of Quebec.Can J Infect Dis Med Microbiol. 2009 Winter;20(4):e163-8. doi: 10.1155/2009/971624. Can J Infect Dis Med Microbiol. 2009. PMID: 21119795 Free PMC article.
-
Antimicrobial Selection in the Treatment of Pyelonephritis.Curr Infect Dis Rep. 2004 Dec;6(6):457-461. doi: 10.1007/s11908-004-0065-7. Curr Infect Dis Rep. 2004. PMID: 15538983
-
Clinical importance and epidemiology of quinolone resistance.Infect Chemother. 2014 Dec;46(4):226-38. doi: 10.3947/ic.2014.46.4.226. Epub 2014 Dec 29. Infect Chemother. 2014. PMID: 25566402 Free PMC article. Review.
-
Fluoroquinolone resistance determinants in carbapenem-resistant Escherichia coli isolated from urine clinical samples in Thailand.PeerJ. 2023 Nov 8;11:e16401. doi: 10.7717/peerj.16401. eCollection 2023. PeerJ. 2023. PMID: 37953793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
